Skip Navigation

Livestream

Create free account

Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman

In this video

Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman

Evan Seigerman, BMO Capital, joins 'Fast Money' to discuss BMO's inaugural GLP-1 conference.

05:05

Wed, Mar 20 20246:07 PM EDT

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

an hour ago

Investors should take some money off the table, says MAI Capital's Chris Grisanti

Investors should take some money off the table, says MAI Capital's Chris Grisanti

2 hours ago

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

3 hours ago

Parabolic tech mania continues: Investors' next move

Parabolic tech mania continues: Investors' next move

4 hours ago

Medtronic CEO says their core business is 'growing well'

Medtronic CEO says their core business is 'growing well'

4 hours ago

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

Goldman's John Waldron: Exuberance is a pretty good word to describe equity markets

an hour ago

Investors should take some money off the table, says MAI Capital's Chris Grisanti

Investors should take some money off the table, says MAI Capital's Chris Grisanti

2 hours ago

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

3 hours ago

Parabolic tech mania continues: Investors' next move

Parabolic tech mania continues: Investors' next move

4 hours ago

Medtronic CEO says their core business is 'growing well'

Medtronic CEO says their core business is 'growing well'

4 hours ago